We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
Pinduoduo
PDD
$112B
| $3.88M | ﹤0.01% |
50,925
+43,716
| +606% | +$4.04M |
2023 Q4
10 quarters
|
|
1427
PUT
Talen Energy Corp
TLN
$16.2B
| $3.88M | ﹤0.01% |
10,100
+4,600
| +84% | +$1.69M |
2026 Q1
1 quarter
|
|
1428
CALL
Genmab
GMAB
$35.1B
| $3.88M | ﹤0.01% |
+141,100
| New | +$3.75M |
2026 Q2
0 quarters
|
|
1429
LKQ Corp
LKQ
$4.68B
| $3.88M | ﹤0.01% |
147,188
+104,450
| +244% | +$2.9M |
2026 Q1
1 quarter
|
|
1430
CALL
ARK Innovation ETF
ARKK
$5.95B
| $3.87M | ﹤0.01% |
+47,900
| New | +$3.66M |
2026 Q2
0 quarters
|
|
1431
CALL
Cogent Biosciences
COGT
$5.38B
| $3.87M | ﹤0.01% |
+100,000
| New | +$3.5M |
2026 Q2
0 quarters
|
|
1432
Fortuna Silver Mines
FSM
$2.63B
| $3.86M | ﹤0.01% |
456,837
-109,926
| -19% | -$1.07M |
2024 Q3
7 quarters
|
|
1433
CALL
Hims & Hers Health
HIMS
$6.46B
| $3.85M | ﹤0.01% |
111,000
-12,600
| -10% | -$338K |
2025 Q1
5 quarters
|
|
1434
Rocket Companies
RKT
$36.2B
| $3.84M | ﹤0.01% |
243,830
-2,562,273
| -91% | -$36.9M |
2025 Q4
2 quarters
|
|
1435
Elevance Health
ELV
$91.1B
| $3.84M | ﹤0.01% |
9,927
-255,733
| -96% | -$94.8M |
2023 Q2
12 quarters
|
|
1436
CALL
Amgen
AMGN
$252B
| $3.84M | ﹤0.01% |
10,600
-900
| -8% | -$308K |
2023 Q3
11 quarters
|
|
1437
Workiva
WK
$4.55B
| $3.83M | ﹤0.01% |
78,981
+58,042
| +277% | +$2.99M |
2025 Q4
2 quarters
|
|
1438
Adtran
ADTN
$532M
| $3.83M | ﹤0.01% |
+275,489
| New | +$4.3M |
2026 Q2
0 quarters
|
|
1439
CALL
iShares Ethereum Trust ETF
ETHA
$7.35B
| $3.83M | ﹤0.01% |
+107,333
| New | +$5M |
2026 Q2
0 quarters
|
|
1440
PUT
D.R. Horton
DHI
$40.8B
| $3.83M | ﹤0.01% |
+23,500
| New | +$3.51M |
2026 Q2
0 quarters
|
|
1441
Northern Oil and Gas
NOG
$3.02B
| $3.82M | ﹤0.01% |
210,592
-61,596
| -23% | -$1.46M |
2023 Q4
10 quarters
|
|
1442
OR Royalties Inc
OR
$5.96B
| $3.81M | ﹤0.01% |
120,488
+104,097
| +635% | +$3.84M |
2025 Q4
2 quarters
|
|
1443
Hess Midstream
HESM
$4.2B
| $3.81M | ﹤0.01% |
101,258
+95,166
| +1,562% | +$3.66M |
2023 Q2
12 quarters
|
|
1444
Prudential
PUK
$30.2B
| $3.78M | ﹤0.01% |
141,126
+108,970
| +339% | +$3.18M |
2026 Q1
1 quarter
|
|
1445
PUT
MP Materials
MP
$7.05B
| $3.77M | ﹤0.01% |
+67,300
| New | +$4.1M |
2026 Q2
0 quarters
|
|
1446
Ferrovial N.V. Ordinary Shares
FER
$39.7B
| $3.76M | ﹤0.01% |
+54,747
| New | +$3.74M |
2026 Q2
0 quarters
|
|
1447
Strategy Inc
MSTR
$55.3B
| $3.75M | ﹤0.01% |
43,092
+20,277
| +89% | +$2.94M |
2023 Q1
13 quarters
|
|
1448
RadNet
RDNT
$5.78B
| $3.74M | ﹤0.01% |
60,683
+26,437
| +77% | +$1.49M |
2025 Q3
3 quarters
|
|
1449
PUT
Circle Internet Group
CRCL
$18.4B
| $3.74M | ﹤0.01% |
59,700
+26,100
| +78% | +$2.54M |
2025 Q2
4 quarters
|
|
1450
CALL
iShares MSCI Japan ETF
EWJ
$23.1B
| $3.73M | ﹤0.01% |
+40,000
| New | +$3.63M |
2026 Q2
0 quarters
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.